Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Experimental approaches

  • Is the oral microbiota representative for the healthy bronchial microbiota?
    S Tangedal, R Nielsen, M Aanerud, H Wiker, C Drengenes, G Husebø, K Knutsen, S Lehmann, T Eagan
    European Respiratory Journal Sep 2022, 60 (suppl 66) 614; DOI: 10.1183/13993003.congress-2022.614
  • The impact of anti-IL5 therapies on patients with severe eosinophilic asthma: a proteomic approach
    P Cameli, L Vantaggiato, M D'Alessandro, L Bergantini, E Shaba, A Carleo, F Di Giuseppe, S Angelucci, L Bini, E Bargagli, C Landi
    European Respiratory Journal Sep 2022, 60 (suppl 66) 197; DOI: 10.1183/13993003.congress-2022.197
  • Ambulatory management of bronchopleural fistulae secondary to empyema
    J Davy, P Tang, M Burton
    European Respiratory Journal Sep 2022, 60 (suppl 66) 257; DOI: 10.1183/13993003.congress-2022.257
  • GTX-003 reduces the fibrotic markers in human lung fibroblast from patients with interstitial lung diseases.
    A Montes Worboys, J Mercade, M Molina-Molina, E Ruiz-Canovas
    European Respiratory Journal Sep 2022, 60 (suppl 66) 295; DOI: 10.1183/13993003.congress-2022.295
  • Estimating the minimum sample size for interventional research using the lung clearance index
    C Bowerman, F Ratjen, S Stanojevic
    European Respiratory Journal Sep 2022, 60 (suppl 66) 78; DOI: 10.1183/13993003.congress-2022.78
  • Diagnostic role of the cough profile in COVID-19 patients
    Clare Davidson, Antonio Caguana, Manuel Lozano-García, M Arita, Luis Estrada-Petrocelli, Ignasi Ferrer-Lluis, Yolanda Castillo-Escario, P Ausín, J Gea, Raimon Jané
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3872; DOI: 10.1183/13993003.congress-2021.PA3872
  • Submicroscopic changes of of hemomicrocirculatory bed of the lungs in long term experimental streptozotocin-induced diabetes mellitus
    Yuliya Fedorchenko, Lubomyr Zaiats
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3608; DOI: 10.1183/13993003.congress-2021.PA3608
  • Generating senescent airway epithelial cell populations using low-concentration doxorubicin or etoposide
    Shyreen Hassibi, Jonathan Baker, Peter Barnes, Louise Donnelly
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3687; DOI: 10.1183/13993003.congress-2021.PA3687
  • Differential effects of Nintedanib and SB525334 in primary human cell-based assays of lungfibrosis
    Vanessa Pitozzi, Paola Caruso, Martina Bonatti, Britt Sotthewes, Jeroen Degroot, Gino Villetti, Maurizio Civelli, Marcello Trevisani, Maria Gloria Pittelli
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3696; DOI: 10.1183/13993003.congress-2021.PA3696
  • NHLRC2 mRNA and protein expression in idiopathic pulmonary fibrosis
    Mervi Kreus, Siri Lehtonen, Johanna Salonen, Reetta Hinttala, Riitta Kaarteenaho
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3282; DOI: 10.1183/13993003.congress-2021.PA3282

Pages

  • Previous
  • Next
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 62
  • Acute lung injury and critical care (82)
  • Asthma and allergy (662)
  • CF and non-CF bronchiectasis (278)
  • COPD and smoking (909)
  • Epidemiology, occupational and environmental lung disease (214)
  • Genetics (60)
  • Interstitial and orphan lung disease (499)
  • Lung biology and experimental studies (318)
  • Lung cancer (282)
  • Lung imaging (45)
  • Lung structure and function (303)
  • Mechanisms of lung disease (145)
  • Paediatric pulmonology (394)
  • Pulmonary pharmacology and therapeutics (141)
  • Pulmonary vascular disease (523)
  • Respiratory clinical practice (171)
  • Respiratory infections and tuberculosis (973)
  • Sleep medicine (267)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • ERS clinical practice guidelines on treatment of sarcoidosis
  • European Respiratory Society guidelines for the diagnosis of asthma in adults
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society